VAXCONSULT: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VAXCONSULT
Largest movements
- Current investments +€97,516
new in 2025: €97,516
- Cash +€76,157
up €76,157 (+42.1%), from €180,750 to €256,907
mainly Net result for the year (+€127,560) and Tax, wage and social debts (+€36,166)
- Profit (loss) carried forward +€119,636
up €119,636 (+86.2%), from €138,821 to €258,458
- Tax, wage and social debts +€36,166
up €36,166 (+91.1%), from €39,680 to €75,846
- Other debts +€14,106
new in 2025: €14,106
- Gross operating margin -€11,765
down €11,765 (-6.6%), from €178,292 to €166,527
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €188,501 | €358,716 | +€170,215 | +90.3% |
| Current assets | 29/58 | €188,501 | €358,716 | +€170,215 | +90.3% |
| Amounts receivable within one year | 40/41 | €7,752 | €4,293 | -€3,458 | -44.6% |
| Trade receivables | 40 | - | €1,272 | +€1,272 | |
| Other amounts receivable | 41 | €7,752 | €3,021 | -€4,730 | -61.0% |
| Current investments | 50/53 | - | €97,516 | +€97,516 | |
| Cash at bank and in hand | 54/58 | €180,750 | €256,907 | +€76,157 | +42.1% |
| Total equity and liabilities | 10/49 | €188,501 | €358,716 | +€170,215 | +90.3% |
| Equity | 10/15 | €148,821 | €268,458 | +€119,636 | +80.4% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €138,821 | €258,458 | +€119,636 | +86.2% |
| Amounts payable | 17/49 | €39,680 | €90,258 | +€50,578 | +127.5% |
| Amounts payable within one year | 42/48 | €39,680 | €90,258 | +€50,578 | +127.5% |
| Trade debts | 44 | - | €306 | +€306 | |
| Suppliers | 440/4 | - | €306 | +€306 | |
| Taxes, remuneration and social security | 45 | €39,680 | €75,846 | +€36,166 | +91.1% |
| Taxes | 450/3 | €39,680 | €75,846 | +€36,166 | +91.1% |
| Other amounts payable | 47/48 | - | €14,106 | +€14,106 | |
| Other operating charges | 640/8 | - | €400 | +€400 | |
| Gross operating margin | 9900 | €178,292 | €166,527 | -€11,765 | -6.6% |
| Operating profit (loss) | 9901 | €178,292 | €166,127 | -€12,165 | -6.8% |
| Financial income | 75/76B | €941 | €2,669 | +€1,727 | +183.5% |
| Recurring financial income | 75 | €941 | €2,669 | +€1,727 | +183.5% |
| Financial charges | 65/66B | €732 | €1,771 | +€1,039 | +142.0% |
| Recurring financial charges | 65 | €732 | €1,771 | +€1,039 | +142.0% |
| Profit (loss) for the period before taxes | 9903 | €178,501 | €167,024 | -€11,477 | -6.4% |
| Income taxes | 67/77 | €39,680 | €39,464 | -€216 | -0.5% |
| Profit (loss) for the period | 9904 | €138,821 | €127,560 | -€11,261 | -8.1% |
| Profit (loss) for the period to be appropriated | 9905 | €138,821 | €127,560 | -€11,261 | -8.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.